Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Haematologica|April 3, 2016
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adultsRohtesh S Mehta, Regis Peffault de Latour, Todd E DeFor, et al.
Transplantation and Cellular Therapy|June 6, 2023
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host DiseaseShernan G Holtan, Andrea Hoeschen, Qing Cao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2018
Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aidKhalid Amin, Usman Yaqoob, Brittney Schultz, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Gut Microbes|March 13, 2024
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trialArmin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
BMC Complementary and Alternative Medicine|September 18, 2010
The effect of chair massage on muscular discomfort in cardiac sonographers: a pilot studyDeborah J Engen, Dietlind L Wahner-Roedler, Anita M Nadolny, et al.
Journal for Immunotherapy of Cancer|February 20, 2019
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibitionElizabeth I Buchbinder, Janice P Dutcher, Gregory A Daniels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid TumorsKim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
Cancers|June 12, 2026
Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot StudyLaura F Newell, Eric Twohey, Jason Sweetnam, et al.
Pageof 15